Skip to Content

Didanosine

In the US, Didanosine (didanosine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF02

CAS registry number (Chemical Abstracts Service)

0069655-05-6

Chemical Formula

C10-H12-N4-O3

Molecular Weight

236

Therapeutic Categories

Antiviral agent

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of HIV infection

Chemical Name

2',3'-Dideoxyinosine

Foreign Names

  • Didanosinum (Latin)
  • Didanosin (German)
  • Didanosine (French)
  • Didanosina (Spanish)

Generic Names

  • Didanosine (OS: BAN, DCF, USAN, JAN)
  • BMY-40900 (IS: Bristol-Myers)
  • DDI (IS)
  • NSC 612049 (IS)
  • Didanosine (PH: BP 2015, Ph. Eur. 8, Ph. Int. 4, USP 37)
  • Didanosinum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names

  • Ai Lue
    Huahai, China
  • Aspen Didanosine
    Aspen Pharmacare, South Africa
  • Bristol-Videx
    Bristol-Myers Squibb, Colombia
  • Cipladinex
    Biotoscana, Colombia
  • DDI Martian
    LKM, Argentina
  • Ddretro
    Alkem, India
  • Didan
    Vitalchem, Colombia
  • Didanosina Dosa
    Dosa, Argentina
  • Dinex
    Wyeth, Venezuela
  • Dinosin
    Hetero, India; Richmond, Argentina
  • Divir
    GPO, Thailand
  • Hate
    NEGPF, China
  • Sonke-Didanosine
    Ranbaxy, South Africa
  • Viden
    Biogen, Colombia
  • Videx
    Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; P & D, Malta; PharmaSwiss, Croatia (Hrvatska)
  • Videx EC
    Bristol-M.S., Argentina; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Estonia; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, United States
  • Virosine-DR
    Ranbaxy, India
  • ZhengYuan
    Topfond Pharmaceutical, China

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide